SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-026284
Filing Date
2024-11-06
Accepted
2024-11-06 20:59:16
Documents
2
Period of Report
2024-11-05

Document Format Files

Seq Description Document Type Size
1 form3-11072024_011112.html 3  
1 form3-11072024_011112.xml 3 5693
2 ex24-11072024_011112.htm EX-24 6315
  Complete submission text file 0001415889-24-026284.txt   13491
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Issuer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VERRICA PHARMACEUTICALS INC. 44 W. GAY ST., SUITE 400 WEST CHESTER PA 19380
Business Address
Rieger Jayson (Reporting) CIK: 0002043558 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38529 | Film No.: 241432774